Start with a CBD-dominant cultivar, not the strongest strain
For a first purchase, choose a lab-tested CBD-dominant hemp cultivar with a CBD to THC ratio of at least 10:1, a current certificate of analysis, and a terpene profile that lists myrcene, beta-caryophyllene, or pinene. Buy a small amount, keep a simple symptom log, and review it with your clinician. If you live in a state where medical cannabis is legal, a balanced 1:1 cultivar is the second step, not the first. The goal is to find the lowest effective dose with the fewest side effects, not the highest potency.
Our pick: ACDC-type CBD-dominant flower
ACDC and similar CBD-dominant cultivars are the safest starting point for most people who want to try cannabis for migraine. These cultivars usually test between 10% and 20% CBD with THC below 1%, so the psychoactive effect is mild. ACDC often carries myrcene and pinene, two terpenes that users describe as relaxing without heavy sedation. The main drawback is inconsistency: two products labeled ACDC can have different chemotypes. Buy only from sellers who publish batch-specific lab results.
What to look for
Ratio and potency
- CBD to THC ratio: 10:1 or higher for a first trial. Balanced 1:1 products are for experienced users in legal medical markets.
- Total THC: Under 0.3% for hemp flower sold online in the US. Medical cannabis products may exceed this under state law.
- CBD range: 8% to 20% for hemp flower. Higher percentages do not mean better results.
Terpenes
Terpenes shape the aroma and may influence the experience. For migraine, users often report benefit from myrcene, beta-caryophyllene, linalool, and pinene. Look for a lab report that lists terpene percentages, not just a marketing name. A cultivar high in pinene may feel more alert; one high in myrcene may feel more sedating. Start with a moderate myrcene level if you need to stay functional.
Medical Marijuana for Migraines: A Comprehensive Buying Guide
Testing and sourcing
A current certificate of analysis from an ISO-accredited lab should cover cannabinoids, terpenes, pesticides, heavy metals, mold, and microbials. Batch numbers matter because cannabis is a plant and potency varies. Avoid sellers who show only a generic lab report or no report at all. For hemp, confirm the product was grown under the 2018 Farm Bill program and that your state allows it.
Medical Cannabis for Migraine Relief: What the Evidence Shows
Compare the options
Harlequin: balanced option for legal medical markets
Harlequin typically carries a 1:1 CBD to THC ratio and a sativa-leaning effect. People who need more breakthrough relief sometimes prefer it, but the THC can cause anxiety or rebound headache in sensitive users. It is not a good first choice if you have never used THC.
Cannatonic: variable ratio, strong CBD profile
Cannatonic is a CBD-dominant cultivar with a ratio that ranges from 1:1 to 2:1 depending on the cut. It often shows myrcene and beta-caryophyllene. Because the ratio varies, always check the batch report. It suits users who want more body relaxation than ACDC provides.
Charlotte's Web: high CBD, low THC
Charlotte's Web is one of the most recognizable high-CBD cultivars. It usually tests above 10% CBD with THC under 0.3%. The effect is mild and functional. The main pitfall is brand dilution: many products use the name without the same chemotype. Verify the lab report and the grower.
Sour Tsunami: high CBD with a sour profile
Sour Tsunami is a CBD-dominant cultivar often used for daytime relief. It carries terpenes such as pinene and limonene. Users who find myrcene-heavy strains too sedating may prefer it. Availability is less consistent than ACDC or Charlotte's Web.
Remedy: CBD-dominant with a mild effect
Remedy is a CBD-rich cultivar with low THC. It is often described as clear-headed. It can be a good alternative for people who need to work or drive later in the day, though you should not drive after use until you know how it affects you.
Pitfalls to avoid
- Chasing THC potency. High-THC products can worsen anxiety and headache in some users.
- Trusting strain names. Cultivar names are not standardized. The lab report is the only reliable guide.
- Skipping the COA. Without batch testing, you cannot rule out mold, pesticides, or inaccurate potency.
- Ignoring drug interactions. CBD can change how the body processes some migraine medications and blood thinners. Ask a pharmacist.
- Using daily without a break. Track use and take tolerance breaks if you notice diminishing returns.
- Expecting a cure. Cannabis may reduce symptoms for some people, but it does not prevent migraine attacks.
FAQ
Can cannabis cure migraines?
No. Evidence is limited, and no cannabis product is approved to prevent or treat migraine. Some people report fewer attacks or less pain, but placebo effects and variable products make personal results hard to interpret.
Should I choose CBD or THC?
Start with CBD-dominant flower. It has less psychoactive effect and a lower risk of anxiety. Move to a balanced ratio only if CBD alone does not help and you live in a legal medical market.
How much should I use?
Start with one small inhalation or a low labeled dose, then wait at least two hours before adding more. Inhaled effects appear within minutes; edible effects can take one to two hours. Keep a log of dose, timing, and symptoms.
Will CBD show up on a drug test?
Possibly. Hemp products can contain trace THC, and cumulative use may trigger a positive result. If you are tested at work, choose a product with a batch report showing non-detect THC and still understand the risk.
Is hemp flower legal in my state?
Federal law allows hemp with under 0.3% THC, but state rules vary. Some states ban smokable hemp or require a medical card for any cannabis product. Check your state health department before buying.
Bottom line
Buy a small amount of lab-tested ACDC-type CBD-dominant flower first. Compare it with Cannatonic or Charlotte's Web if you want a different terpene profile. Reserve Harlequin and other balanced cultivars for legal medical markets and experienced users. Track your results and talk to your clinician before combining cannabis with migraine medication.